Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide add-on to intensive insulin in C-peptide positive type 1 diabetes
2014-001381-96Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- May 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of liraglutide in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Medical University of Graz. Started May 2014; status: completed.
02
Drugs
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-001381-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001381-96.